°­ÀǽÅûRegistration

ÆÐÅ°Áö°­ÀÇ

Ȩhome > °­ÀǽÅû > ÆÐÅ°Áö°­ÀÇ

°­Á¼Ұ³ ¹× ¸ñÂ÷
  • ÆÐÅ°ÁöÀ̹ÌÁö

    °­Á¸í
    ½ÇÀüÀÓ»ó¾àÇÐ 1 [ÀÓ»ó¾àÇÐ ±âÃÊ]
    °­Á¼Ұ³
    º» °­ÀǸ¦ ¼ö°­ÇÏ´Â Àϼ± ¾à»ç´ÔµéÀº ¼±ÁøÀÓ»ó¾àÇп¡ ´ëÇÑ °³³ä°ú Áö½ÄÀ» ȹµæÇÏ¿© ¾à¹« ÇöÀå¿¡¼­ ȯÀÚ¿¡ ´ëÇÑ Ä¡·á¸¦ °­È­ÇÏ°í À̸¦ ½ÇÁ¦ÀûÀ¸·Î Àû¿ëÇÔÀ¸·Î½á ¾à±¹ °æ¿µ°ú Á÷´ÉÀÇ Àü¹®¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

    °¢ °úÁ¤Àº Áúȯº° º´Å»ý¸®, ÀÓ»óÁõ»ó, ¾à¹°Ä¡·á¸¦ Áß½ÉÀ¸·Î °­ÀÇ°¡ ÁøÇàµÇ¸ç,
    º» °­ÀÇ [ÀÓ»ó¾àÇÐ Session 1 ÀÓ»ó¾àÇÐÀÇ ±âÃÊ]´Â Áúȯº° º» °­Á·Π³ª°¡±â¿¡ ¾Õ¼­ ÀǾàÁ¤º¸, ¾à¹°¿ä¹ýÀÇ ¸ð´ÏÅ͸µ ¹× ȯÀÚ»ó´ã, ÀÓ»óº´¸® °Ë»çÀÇ Çؼ³, Áßµ¶ÀÇ °ü¸®, Á¾¾çÇÐ ¹× °¨¿°Áúȯ °³·Ð µî ±âÃÊÀûÀÎ Áö½ÄÀ» ½ÀµæÇÒ ¼ö ÀÖ´Â °­ÁÂÀÔ´Ï´Ù.

    ¹Ì±¹ ¾àÇдëÇп¡¼­ ÆʵðÇÐÀ§¸¦ ÃëµæÇÏ°í ÇöÀç ±¹³» Á¦¾à»ç, º´¿ø, ¾à±¹, ´ëÇп¡¼­ ¿Õ¼ºÇÏ°Ô È°µ¿ ÁßÀÎ ±³¼öÁøÀÌ ÁÖÃàÀÌ µÇ¾î Áö±Ý±îÁö ¹è¿ì°í ÀÍÇû´ø ¼±ÁøÀÓ»ó¾àÇÐ Áö½Ä°ú ½ÇÁ¦ ±Ù¹«ÇöÀå¿¡¼­ üµæÇÑ ½ÇÀü °æÇèÀ» ¹ÙÅÁÀ¸·Î Àϼ± ¾à»ç´Ôµé¿¡°Ô °­ÀǸ¦ Á¦°ø ÇÕ´Ï´Ù.

    °¢ °úÁ¤Àº Áúȯº° º´Å»ý¸®, ÀÓ»óÁõ»ó, ¾à¹°Ä¡·á¸¦ Áß½ÉÀ¸·Î °­ÀÇ°¡ ÁøÇàµÇ¸ç,
    º» °­ÀÇ °­ÀÇ [Session 1 ÀÓ»ó¾àÇÐÀÇ ±âÃÊ]´Â Áúȯº° º» °­Á·Π³ª°¡±â¿¡ ¾Õ¼­ ÀǾàÁ¤º¸, ¾à¹°¿ä¹ýÀÇ ¸ð´ÏÅ͸µ ¹× ȯÀÚ»ó´ã, ÀÓ»óº´¸® °Ë»çÀÇ Çؼ³, Áßµ¶ÀÇ °ü¸®, Á¾¾çÇÐ ¹× °¨¿°Áúȯ °³·Ð µî ±âÃÊÀûÀÎ Áö½ÄÀ» ½ÀµæÇÒ ¼ö ÀÖ´Â °­ÁÂÀÔ´Ï´Ù.

    [°­»ç¼Ò°³]

    ¾ç¼ºÈñ Pharm.D.

    - ¼­¿ï´ëÇб³ ¾àÇаú Á¹¾÷
    - University of Florida, Pharm.D.
    - Àü) °¡Å縯´ëÇб³ °­³²¼º¸ðº´¿ø ¾àÁ¦°ú
    - Àü) Çѱ¹º´¿ø ¾àÁ¦°ú
    - Àü) Á¦ÁÖ ÇѶó´ëÇÐ ÀÓ»ó¾à¸®ÇÐ °­»ç
    - Çö) Medstat(ÀÇÇÐÅë°è ÄÁ¼³ÆÃ) ´ëÇ¥
    - Çö) ¹Ì±¹/ij³ª´Ù¾à»ç¸éÇãÃëµæ±³À°°úÁ¤ °­»ç

    Á¶Çý°æ Pharm.D.

    - ¼­¿ï´ëÇб³ ¾àÇаú Á¹¾÷
    - U . Of Wisconsin-Madison, Pharm.D.
    - Àü) ÀÌÈ­¿©ÀÚ´ëÇб³ ±³¼ö
    - Çö) Çѱ¹BMS ÀÌ»ç

    ±èÇý°æ Pharm.D., Ph.D.

    - °æ¼º´ëÇб³ ¾àÇаú, ¾àÇйڻç
    - University of Florida, Pharm.D.
    - ¹Ì±¹ Ķ¸®Æ÷´Ï¾ÆÁÖ ¾à»ç
    - Çö) °æ¼º´ëÇб³ ÀÓ»ó¾àÇÐ ¿Ü·¡°­»ç
    - Çö) ÀüºÏ´ëº´¿ø ÀÓ»ó½ÃÇè¼¾ÅÍ ±â´É¼º½ÄÇ° °³¹ßÆÀÀå
    - Çö) ºÎ»ê´ëÇб³ º´¿ø ¾àÁ¦°ú
    °­Á ±â°£/°¡°Ý
    30 / 200,000¿ø
    ±³Àçºñ
    15,000¿ø
    °­Á¸ñÂ÷
    1) 1. ÀǾàÁ¤º¸ (Medical Information) (1)
    2) 2. ÀǾàÁ¤º¸ (Medical Information) (2)
    3) 3. ¹®ÇåÆò°¡ (Literature Evaluation)
    4) 4. »ý¹°Åë°è (Biostatistics)
    5) 5. ȯÀÚÀÇ ¾à¹°Ä¡·á °ü¸® (1)
    6) 6. ȯÀÚÀÇ ¾à¹°Ä¡·á °ü¸® (2) & Diagnostic Tools (1)
    7) Diagnostic Tools (Laboratory & Physical Exam) (2)
    8) 8. Diagnostic Tools (Laboratory & Physical Exam) (3)
    9) 9. Communication with patients (1)
    10) Communication with patients (2)
    11) Anaphylaxis and serious drug reaction
    12) Assessment of drug-drug interaction
    13) ¼Ò¾ÆȯÀÚÀÇ ¾à¹°¿ä¹ý
    14) ³ëÀÎȯÀÚÀÇ ¾à¹°¿ä¹ý
    15) Introduction to infectious disease
    16) Introduction to Oncology
No °­ÁÂ¸í ´ã´ç±³¼ö ¼ö°­±â°£ ¼ö°­·á ±³Àçºñ °­ÀÇ»ùÇÄ ¼ö°­½Åû
1 »ì¾ÆÀÖ´Â º¹¾àÁöµµ 2 ±è¼ºÃ¶ 34°­
(60ÀÏ)
200,000¿ø50,000¿ø  ¼ö°­
2 °Ç°­±â´É½ÄÇ°°ú Áúº´º° ¿µ¾ç¿ä¹ý ¹Ú¿µ¼ø 74°­
(60ÀÏ)
200,000¿ø0¿ø ¼ö°­
3 À£ºùÄɾÅä¾î Ư°­ ¹Ú¿µ¼ø 1°­
(10ÀÏ)
10,000¿ø0¿ø  ¼ö°­
4 ´Ùºóµµ Áúȯ Ư°­ ¹Ú¿µ¼ø 18°­
(30ÀÏ)
100,000¿ø0¿ø  ¼ö°­
5 ÀϹÝÀǾàÇ° ¿ÏÀüÁ¤º¹ ¹Ú±Ôµ¿ 40°­
(60ÀÏ)
240,000¿ø7,000¿ø  ¼ö°­
6 ½ÇÀüÀÓ»ó¾àÇÐ 1 [ÀÓ»ó¾àÇÐ ±âÃÊ] ¹Ì±¹ Pharm.D. 16°­
(30ÀÏ)
200,000¿ø15,000¿ø  ¼ö°­
7 ½ÇÀüÀÓ»ó¾àÇÐ 2 [È£Èí±â/ÇǺÎ/¾È°ú Áúȯ] ¹Ì±¹ Pharm.D. 15°­
(30ÀÏ)
200,000¿ø15,000¿ø  ¼ö°­
8 ½ÇÀüÀÓ»ó¾àÇÐ 3 [³»ºÐºñ Áúȯ/½ÉÇ÷°ü Áúȯ] ¹Ì±¹ Pharm.D. 18°­
(50ÀÏ)
250,000¿ø15,000¿ø  ¼ö°­
9 ½ÇÀüÀÓ»ó¾àÇÐ 4 [¼ÒÈ­±â Áúȯ/½ÅÀå Áúȯ] ¹Ì±¹ Pharm.D. 19°­
(50ÀÏ)
250,000¿ø10,000¿ø  ¼ö°­
10 ½ÇÀüÀÓ»ó¾àÇÐ 5 [½Å°æÁúȯ/Á¤½Å Áúȯ/¸é¿ª Áúȯ] ¹Ì±¹ Pharm.D. 15°­
(30ÀÏ)
200,000¿ø10,000¿ø  ¼ö°­
11 ÇÁ¸®¹Ì¾ö ¸â¹ö½± ÆÊ³Ý °­»çÁø 0°­
(365ÀÏ)
800,000¿ø0¿ø  ¼ö°­
12 »ì¾ÆÀÖ´Â º¹¾àÁöµµ 1 ±è¼ºÃ¶ 23°­
(60ÀÏ)
250,000¿ø50,000¿ø  ¼ö°­
13 Á¾ÀÌ ÇÑÀåÀ» À§ÇÑ °­ÀÇ ¹Ú¿µ¼ø 17°­
(60ÀÏ)
300,000¿ø0¿ø ¼ö°­
14 Çѹ氭Á ¹Ú¿µ¼ø 67°­
(60ÀÏ)
200,000¿ø50,000¿ø ¼ö°­

¸ð¹ÙÀϹöÀü